Correction to: Prostate Cancer and Prostatic Diseases https://doi.org/10.1038/s41391-023-00696-w, published online 17 July 2023
In this article the author name Srivastava was incorrectly written as Strivastava.
The following sentence
Of these 205 patients, 146 individuals received ADT intensification with ARPIs, while 59 received ADT intensification with docetaxel.
should read
Of these 205 patients, 149 individuals received ADT intensification with ARPIs, while 56 received ADT intensification with docetaxel.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gebrael, G., Sayegh, N., Thomas, V.M. et al. Correction: Survival outcomes of real world patients with metastatic hormone-sensitive prostate cancer who do not achieve optimal PSA response with intensified androgen deprivation therapy with docetaxel or androgen receptor pathway inhibitors. Prostate Cancer Prostatic Dis (2023). https://doi.org/10.1038/s41391-023-00706-x
Published:
DOI: https://doi.org/10.1038/s41391-023-00706-x
